Evidence domain	Included studies	Interpretive weight
Direct neurologic workflow/management	10	Consensus and implementation guidance; useful operational evidence but limited comparative testing
Neurodiagnostic/biomarker evidence	8	Mostly observational or pilot evidence; supports selective testing and future validation
Direct neurotoxicity/ICANS evidence	6	Mixed meta-analytic, cohort, and case-level evidence
Therapy-specific safety context	2	Clinical-trial context; not designed primarily to compare neurologic workflows